Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

NCT00956670 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1055

Last updated 2017-05-08

No results posted yet for this study

Summary

This clinical trial studies lymphedema after surgery in patients with endometrial cancer, cervical cancer, or vulvar cancer. Collecting information over time about how often lymphedema occurs in patients undergoing surgery and lymphadenectomy for endometrial cancer, cervical cancer, and vulvar cancer may help doctors learn more about the disease and plan the best treatment.

Conditions

  • Lymphedema
  • Stage IA Cervical Cancer
  • Stage IA Uterine Corpus Cancer
  • Stage IA Vulvar Cancer
  • Stage IB Cervical Cancer
  • Stage IB Uterine Corpus Cancer
  • Stage IB Vulvar Cancer
  • Stage II Uterine Corpus Cancer
  • Stage II Vulvar Cancer
  • Stage IIA Cervical Cancer
  • Stage IIIA Vulvar Cancer
  • Stage IIIB Vulvar Cancer
  • Stage IIIC Vulvar Cancer
  • Stage IVB Vulvar Cancer

Interventions

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Study of High Risk Factors

Undergo lymphedema assessment

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

PROCEDURE

Therapeutic Laparoscopic Surgery

Undergo surgery

PROCEDURE

Therapeutic Lymphadenectomy

Undergo lymphadenectomy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Richard Barakat · NRG Oncology

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00956670 on ClinicalTrials.gov